Teva Pharmaceutical Industries (TEVA) Change in Accured Expenses (2025 - 2026)
Teva Pharmaceutical Industries (TEVA) posted quarterly Change in Accured Expenses of -$144.0 million for Q1 2026, down 251.22% year-on-year from $95.2 million in Q1 2025, and down 251.22% on a QoQ basis from -$41.0 million in Q1 2025.
Teva Pharmaceutical Industries (TEVA) Change in Accured Expenses (2025 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has reported Change in Accured Expenses for 2 consecutive years, with -$144.0 million the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -144.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -234.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -12.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -14.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -144.00 Mn |
| Mar 31, 2026 | -144.00 Mn |
| Mar 31, 2025 | -41.00 Mn |
| Mar 31, 2025 | -41.00 Mn |